A comprehensive analysis of data from the TCGA, GEO, and other multicenter cohorts has revealed that ITM2A exhibits distinct low expression patterns in TNBC tissues, which is notably lower compared with other breast cancer subtypes (p<0.001). This evidence concerns the gene ITM2A and breast carcinoma.